Polfarmex to increase production thanks to a new packaging line
Polfarmex has invested in a new packaging line, which has appeared at its production plant in Kutno. Thanks to the…
leki biopodobne
Samsung announced $205bn investment plan
By 2023, Samsung will invest as much as $205bn in its pharmaceutical, biopharmaceutical, semiconductor and telecommunications industries. This investment is…
Dirk Kreder is the new president of Mabion
Dirk Kreder was appointed president of the Polish biotechnology company Mabion. New president of Mabion Dirk Kreder has extensive experience…
Biosimilar medicines: Sandoz will comercialise Polpharma’s SM drug
Polpharma Biologics and global generic giant Sandoz will jointly launch a biosimilar to the multiple sclerosis (SM) biological drug. This…
Mabion will develop three new biosimilars
Mabion, a Polish biotechnology company, announced that it will start developing three new biosimilar drugs in the second half of…
Mabion with a building permit
On 14 November, Mabion announced that it had received a permit to build “Centrum Naukowo-Technologiczny Zaawansowanej Biotechnologii Medycznej Mabion SA”…
